LOWER GIT Flashcards
Neurotransmitter that relaxes lower esophageal sphincter
GABA (Gamma-amino butyric acid)
Neurotransmitter that decreases motility
Norepinephrine
Sites of release for the norepinephrine
CNS, spinal cord, sympathetic nerves
Neurotransmitter that increases contraction of sphincters
Norepinephrine
Neurotransmitter that inhibits secretions
Norepinephrine
Neurotransmitter that inhibits secretions
Norepinephrine
Site of release of acetylcholine
Central nervous system, autonomic system, other tissues
Neurotransmitter that increases motility
Acetylcholine
Neurotransmitter that relaxes sphincters
Acetylcholine
Neurotransmitter that stimulates secretion
Acetylcholine
Neurotransmitter that stimulates secretion
Acetylcholine
Differentiate acetylcholine and norepinephrine
Norepinephrine decreases motility, increases contraction of sphincters, inhibits secretion and is released at the CNS, spinal cord, and sympathetic nerves
Acetylcholine increases motility, relaxes sphincters, stimulates secretion and is released at the CNS, autonomic system, and other tissues
Neurotransmitter that inhibits release of gastric emptying and acid secretion
Neurotensin
Neurotransmitters that inhibits acid secretion
Neurotensin
Primary action of neurotensin
Inhibits release of gastric emptying and acid secretion
Neurotransmitter that facilitates secretion and peristalsis
Serotonin (5-HT)
Site of Release of GABA
CNS
Site of release of serotonin (5-HT)
GI tract and spinal cord
Site of release of neurotensin
GI tract and CNS
Neurotransmitter that released at the CNS and GI tract
Nitric oxide, neurotensin
Primary actions of nitric oxide (3)
Regulates blood flow
Maintains muscle tone
Maintains gastric motor activity
Neurotransmitter that increases sensory awareness
Substance P
Primary actions of substance P
Increases sensory awareness (mainly pain)
Peristalsis
Site of release of substance P
Gut, CNS, skin
7 examples of neurotransmitters
GABA (Gamma Amino Butyric Acid)
Norepinephrine
Acetylcholine
Neurotensin
Serotonin (5-HT)
Nitric Oxide
Substance P
Major Gastrointestinal Hormones (7)
Gastrin
Secretin
CCK (Cholecystokinin)
GIP (Gastric Inhibitory Polypeptide)
Motilin
GLP-1 (Glucagon-like peptide-1)
GLP-2 (Glucagon-like peptide-2)
Site of release of gastrin
G cells of gastric mucosa and duodenum
Hormone that is released due to stimulants like interdigestive periods and alkaline pH in the duodenum
Motilin
Hormone and its stimulant that affects the stomach, small bowel, and colon
Hormone: Motilin
Stimulant:
Interdigestive periods, alkaline pH in duodenum
Primary action of motilin on the stomach, small bowel, and colon
Promotes gastric emptying and GI motility
Site of release of motilin
M cells of duodenum and jejunum
Hormone released at the site of L cells of small intestine and colon (density increases in distal GIT)
GLP-1 and GLP-2
Hormone stimulated by presence of glucose, fat, and SCFA
GLP-1 and GLP-2
Hormone that affects the stomach and pancreas
GLP-1
Hormone that affects the small intestine and colon
GLP-2
Hormone that affects stomach such that it promotes gastric emptying
GLP-1
Hormone that affects the pancreas by inhibiting glucagon release and stimulating insulin release
GLP-1
Primary action of GLP-2 in the intestine and colon
Stimulates intestinal growth and nutrient digestion and absorption
Site of release of Gastrin
G cells of gastric mucosa and duodenum
Stimulants of gastrin that can affect the stomach, esophagus, and GIT in general
peptides, amino acids, and caffeine
distention in antrum
some alcoholic beverages and vagus nerve
Organs that are affected when gastrin is stimulated by alcoholic beverages
stomach, esophagus, and GIT in general
gallbladder
pancreas
primary action of gastrin to the stomach, esophagus, and GIT in general when stimulated by peptides amino acids and caffeine
stimulates secretion of HCl and pepsinogen
primary action of gastrin to the stomach, esophagus, and GIT in general when stimulated by antrum distention
Increase in gastric antral motility
primary action of gastrin to the stomach, esophagus, and GIT in general when stimulated by alcoholic beverages and vagus nerve
increases lower esophageal sphincter tone
primary action of gastrin in the gallbladder
weakly stimulates contraction of gallbladder
primary action of gastrin in pancreas
weakly stimulates secretion of bicarbonate
affected organs of secretin
pancreas and duodenum
primary action of secretin in pancreas
increase in water and bicarbonate production
increase in pancreatic enzyme and insulin production
hormone whose site of release is the S cells of the duodenum
secretin
Hormone that is released due to a stimulant such as acid in small intestine
secretin
primary action of secretin in the duodenum
decreases it motility and increases mucus output
site of release of CCK
I cells of duodenum
organs affected by CCK when stimulated by peptides, amino acids, fat, and HCl
pancreas, gallbladder, stomach, colon
CCK effect on pancreas
stimulates secretion of pancreatic enzymes
CCK primary action on stomach
slows gastric emptying
CCK primary action on gallbladder
causes gallbladder contraction
CCK primary action on colon
increases motility and may mediate feeding behavior
Hormone whose site of release is K cells of duodenum and jejunum
GIP
stimulants for GIP release
glucose and fat
Organ affected by the GIP
Stomach
primary action of GIP
reduce intestinal motility
symptoms in the cognitive area as an effect of enteroimmune disease
Mental log, poor concentration, learning difficulties, poor memory, lethargy, apathy, rage, restlessness, hyperactivity
symptoms in the sensory area as an effect of enteroimmune disease
Vertigo, lightheadedness, tinnitus
symptoms in emotionally as an effect of enteroimmune disease
Anxiety, moodiness, depression, aggressiveness, irritability
symptoms experienced somatically as an effect of enteroimmune disease
Headaches, insomnia, fatigue, joint pain, muscle pain, stiffness, weakness, weight gain, fluid retention, non-ischemic chest pain
symptoms experienced in the gastrointestinal tract as an effect of enteroimmune disease
Dyspepsia, bloating, belching, constipation, abdominal cramping, nausea, excessive flatulence
symptoms experienced in respiratory system as an effect of enteroimmune disease
Congestion, excessive phlegm and mucous, dyspnea, chronic cough, gagging
Neurologic Diseases associated with enteroimmunopathies
Autism
Alzheimer’s disease
Parkinson’s disease
Multiple sclerosis
Depression
Bipolar disorder
Schizophrenia
Migraine headaches
Cerebellar ataxia
Certain seizure disorders
Diseases associated with inflammation
Cancer
Diabetes
Cardiovascular Disease
Neurological Diseases
Alzheimer’s Disease
Autoimmune Disease
Arthritis
Pulmonary Diseases
Factors that affect the microbiome
Geography
Birth route
Genetics
Hygiene
Diet/Nutrition
Stress
Drugs
What happens if there is healthy microbiome complexity and stability?
Protection against pathogens
Immune function is traned/stimulated
Nutrients, Energy, Vitamin, SCFA are supplied
What happens if there is perturbation in microbiome complexity and stability
Inflammation (local>systemic)
Oxidative stress
Increase in Gram-negative bacteria
Infection (opportunistic/pathogenic)
Altered metabolite production